Literature DB >> 16311338

Nucleus accumbens long-term depression and the expression of behavioral sensitization.

Karen Brebner1, Tak Pan Wong, Lidong Liu, Yitao Liu, Paul Campsall, Sarah Gray, Lindsay Phelps, Anthony G Phillips, Yu Tian Wang.   

Abstract

Drug-dependent neural plasticity related to drug addiction and schizophrenia can be modeled in animals as behavioral sensitization, which is induced by repeated noncontingent or self-administration of many drugs of abuse. Molecular mechanisms that are critical for behavioral sensitization have yet to be specified. Long-term depression (LTD) of alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid receptor (AMPAR)-mediated synaptic transmission in the brain has been proposed as a cellular substrate for learning and memory. The expression of LTD in the nucleus accumbens (NAc) required clathrin-dependent endocytosis of postsynaptic AMPARs. NAc LTD was blocked by a dynamin-derived peptide that inhibited clathrin-mediated endocytosis or by a GluR2-derived peptide that blocked regulated AMPAR endocytosis. Systemic or intra-NAc infusion of the membrane-permeable GluR2 peptide prevented the expression of amphetamine-induced behavioral sensitization in the rat.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311338     DOI: 10.1126/science.1116894

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  130 in total

1.  Extinction training after cocaine self-administration induces glutamatergic plasticity to inhibit cocaine seeking.

Authors:  Lori A Knackstedt; Khaled Moussawi; Ryan Lalumiere; Marek Schwendt; Matthias Klugmann; Peter W Kalivas
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

2.  Sapap3 deletion causes mGluR5-dependent silencing of AMPAR synapses.

Authors:  Yehong Wan; Guoping Feng; Nicole Calakos
Journal:  J Neurosci       Date:  2011-11-16       Impact factor: 6.167

3.  PKMzeta maintains memories by regulating GluR2-dependent AMPA receptor trafficking.

Authors:  Paola Virginia Migues; Oliver Hardt; Dong Chuan Wu; Karine Gamache; Todd Charlton Sacktor; Yu Tian Wang; Karim Nader
Journal:  Nat Neurosci       Date:  2010-04-11       Impact factor: 24.884

4.  Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens.

Authors:  Brad A Grueter; Gabor Brasnjo; Robert C Malenka
Journal:  Nat Neurosci       Date:  2010-11-14       Impact factor: 24.884

5.  A Role for p38 Mitogen-activated Protein Kinase-mediated Threonine 30-dependent Norepinephrine Transporter Regulation in Cocaine Sensitization and Conditioned Place Preference.

Authors:  Padmanabhan Mannangatti; Kamalakkannan NarasimhaNaidu; Mohamad Imad Damaj; Sammanda Ramamoorthy; Lankupalle Damodara Jayanthi
Journal:  J Biol Chem       Date:  2015-02-27       Impact factor: 5.157

Review 6.  Integrating synaptic plasticity and striatal circuit function in addiction.

Authors:  Brad A Grueter; Patrick E Rothwell; Robert C Malenka
Journal:  Curr Opin Neurobiol       Date:  2011-10-12       Impact factor: 6.627

Review 7.  Probing the role of AMPAR endocytosis and long-term depression in behavioural sensitization: relevance to treatment of brain disorders, including drug addiction.

Authors:  Y T Wang
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

8.  Regulation of dendritic excitability by activity-dependent trafficking of the A-type K+ channel subunit Kv4.2 in hippocampal neurons.

Authors:  Jinhyun Kim; Sung-Cherl Jung; Ann M Clemens; Ronald S Petralia; Dax A Hoffman
Journal:  Neuron       Date:  2007-06-21       Impact factor: 17.173

9.  Acute ketamine induces hippocampal synaptic depression and spatial memory impairment through dopamine D1/D5 receptors.

Authors:  Ting-Ting Duan; Ji-Wei Tan; Qiang Yuan; Jun Cao; Qi-Xin Zhou; Lin Xu
Journal:  Psychopharmacology (Berl)       Date:  2013-03-14       Impact factor: 4.530

10.  Disrupting GluA2 phosphorylation potentiates reinstatement of cocaine seeking.

Authors:  Lisa A Briand; Andre U Deutschmann; Alexandra S Ellis; Anne Q Fosnocht
Journal:  Neuropharmacology       Date:  2016-09-10       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.